Viewing nowCombinationSchwazet Tablets 10/20 mg (Ezetimibe, Rosuvastatin)
Ezetimibe 10mg · Rosuvastatin Calcium Micronized 20.8mg
Tablet · Prescription medication · Combination
Anguk Pharmaceutical Co., Ltd.

MFDS item code 201606048 · Approved 2016.10.12 · Insurance code 650204720
Improvement of primary hypercholesterolemia and mixed dyslipidemia
This medication helps patients with primary hypercholesterolemia and mixed dyslipidemia reduce elevated total cholesterol and LDL cholesterol, Apo B protein, triglycerides, and non-HDL cholesterol, and increase HDL cholesterol when taken with a dietary regimen. It is particularly suitable for those at high risk of atherosclerotic vascular diseases due to hypercholesterolemia, and medication treatment is recommended when dietary control and non-drug therapy are insufficient. Before starting this medication, other causes of dyslipidemia such as diabetes and hypothyroidism should be identified, and necessary treatments should be implemented; regular lipid testing to monitor treatment effectiveness is crucial. This medication is used to lower the risk of cardiovascular diseases and improve health through effective cholesterol control.
Administer this medicine once daily, regardless of meals. Patients must continue to follow a standard cholesterol-lowering diet before starting and while taking this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range is 10/5 mg to 10/20 mg once daily. The recommended starting dose is 10/5 mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting this medicine or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly; the dose may be increased up to a maximum of 10/20 mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.
This medication is composed of the active ingredients rosuvastatin and ezetimibe and is primarily used for the treatment of hypercholesterolemia. Prior to taking this medication, caution is necessary if there is a history of muscle problems or a high risk of rhabdomyolysis. Rhabdomyolysis is a serious condition where muscles are severely damaged, which can affect kidney function. Patients with risk factors such as severe infections, hypotension, major surgery, trauma, metabolic, and electrolyte disorders may need to temporarily stop or discontinue taking this medication. Those allergic to the components of this medication or who have severely impaired liver function, muscle disorders, pregnant or nursing women should not take it. Additionally, it is contraindicated for patients with very poor kidney function or those taking cyclosporine. This medication contains lactose, so patients with lactose intolerance or related genetic disorders should not take it. Alcoholics, patients with a history of liver disease, the elderly, and patients with hypothyroidism, who are at higher risk of myopathies, should use caution and require regular examinations according to physician guidance. If symptoms such as muscle pain, muscle cramps, muscle weakness, fatigue, fever, etc., occur during treatment, notify a doctor immediately, and if necessary, check for muscle damage through blood tests. Liver function abnormalities may occur, so liver function tests should be conducted before and during treatment, and dosage adjustments or discontinuation should be considered if liver enzyme levels rise. This medication may slightly elevate blood glucose levels; however, due to its greater cardiovascular disease preventive effects, patients requiring blood sugar management should be observed continuously. There may be interactions when taken with other medications, so especially when used with anticoagulants, fibrate drugs, some antibiotics, and antifungals, consultation with a doctor or pharmacist is advised. It should not be taken during pregnancy or nursing as it may harm the fetus or infant, and women of childbearing age should take appropriate contraceptive measures during treatment. Safety in children and adolescents has not been well established, so it is not recommended. In the case of overdose, as no specific antidote exists, appropriate treatment and supportive care according to symptoms should be administered, and liver function and muscle status monitored periodically. Store this medication out of reach of children and do not transfer it to another container.
nasopharyngitis, arthralgia, headache, elevated ALT, elevated AST, myalgia, edema, increased serum bilirubin, acneiform dermatitis, pruritus, dizziness, upper respiratory infection, chest pain, facial edema, strange sensation, drug intolerance, colon polyps, irritable bowel syndrome, esophagitis, somnolence, neurodegenerative disorders, postural dizziness, migraine, diabetes mellitus, glucose tolerance impairment, depression, bronchitis, rhinitis, cystitis, onychomycosis, soft tissue infection, hepatic steatosis, liver dysfunction, hepatotoxicity, acute hepatitis, toxic hepatitis, increased gamma-glutamyl transferase, increased blood cholesterol, increased serum alkaline phosphatase, irregular heart rate, osteoarthritis, osteoporosis, musculoskeletal stiffness, musculoskeletal discomfort, muscle weakness, diaphoresis, dermatitis, skin burning sensation, skin disorders, alopecia, oropharyngeal pain, nasal congestion, respiratory distress, pelvic pain, breast cysts, eyelid droop, diabetic retinopathy, ear discomfort, renal dysfunction, benign esophageal neoplasm, angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myopathy, rhabdomyolysis, asthenia, thrombocytopenia, jaundice, hepatitis, Stevens-Johnson syndrome, drug reaction syndrome with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, sleep disturbances, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, memory impairment, forgetfulness, amnesia, memory disorder, confusion, severe muscle weakness, ocular muscle weakness, fatigue, chest pain, chest discomfort, generalized edema, diabetic neuropathy, tremor, epigastric pain, vomiting, gastritis, dry mouth, epigastric discomfort, belching, gastrointestinal disorders, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, cough, sputum, runny nose, limb pain, diabetes mellitus, hypoglycemia, anemia, splenomegaly, hyperhidrosis, conjunctival hyperemia, renal failure, abnormal liver function, increased serum creatinine, elevated blood pressure, increased blood urea, increased CPK, abnormal liver function tests
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air or moisture and should be kept at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the medication's efficacy longer.
Pink oblong film-coated tablets
30 tablets/box [10 tablets/PTP X 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEzetimibe 10mg · Rosuvastatin Calcium Micronized 20.8mg
Tablet · Prescription medication · Combination
Anguk Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium Micronized 5.2mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Rosuvastatin Calcium Micronized 20.8mg
Tablet · Prescription medication · Combination
Hyundai Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication · Combination
Hyundai Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Rosuvastatin Calcium Micronized 5.2mg
Tablet · Prescription medication · Combination
Hyundai Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Rosuvastatin Calcium Micronized 5.2mg
Tablet · Prescription medication · Combination
Boryung Co., Ltd.
CombinationRosuvastatin Calcium Micronized 10.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium Micronized 20.8mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.